Anticoagulant Reversal Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Feb 2019| TMR1383A| Transparency

Report Highlights

Global Anticoagulant Reversal Drugs Market: Overview

The global anticoagulant reversal drugs market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global anticoagulant reversal drugs market.

Global Anticoagulant Reversal Drugs Market: Key Segments

In terms of product, the global anticoagulant reversal drugs market has been segmented into prothrombin complex concentrates, vitamin K, protamine, tranexamic acid, idarucizumab, AndeXXa, and others. Based on distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is anticipated to expand at a high CAGR during the forecast period. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Anticoagulant Reversal Drugs Market: Regional Outlook

Geographically, the global anticoagulant reversal drugs market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global anticoagulant reversal drugs market include Bausch Health Companies, Inc., Pfizer, Inc., Fresenius Kabi AG, Amneal Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, CSL Limited, Octapharma AG, Portola Pharmaceuticals, Inc., and Perosphere Pharmaceuticals, Inc.

The global anticoagulant reversal drugs market has been segmented as follows:

Global Anticoagulant Reversal Drugs Market, by Product
Prothrombin Complex Concentrates (PCC)
Vitamin K
Protamine
Tranexamic Acid
Idarucizumab
AndeXXa
Others

Global Anticoagulant Reversal Drugs Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others

Global Anticoagulant Reversal Drugs Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Israel
Rest of Middle East & Africa

  • Table 1 : Reimbursement Scenario for AndeXXa
  • Table 2 : Reimbursement Scenario for Praxbind
  • Table 3 : Reimbursement Scenario for Kcentra
  • Table 4 : Pipeline Analysis
  • Table 5 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 6 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 7 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
  • Table 8 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 10 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 11 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 12 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 13 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 14 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 15 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 16 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 17 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 18 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 19 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 20 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Product, 2016–2026
  • Table 22 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Anticoagulant Reversal Drugs Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 2 : Global Anticoagulant Reversal Drugs Market Size (US$ Mn) and Forecast, 2018–2026
  • Figure 3 : Market Value Share, by Product (2018)
  • Figure 4 : Market Value Share, by Distribution Channel (2018)
  • Figure 5 : Market Value Share, by Region (2018)
  • Figure 6 : Regulatory Approval Process - U.S.
  • Figure 7 : Regulatory Approval Process - Europe
  • Figure 8 : Regulatory Approval Process - Japan
  • Figure 9 : Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 10 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Prothrombin Complex Concentrates (PCC) 2016–2026
  • Figure 11 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Vitamin K, 2016–2026
  • Figure 12 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Protamine, 2016–2026
  • Figure 13 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Tranexamic Acid, 2016–2026
  • Figure 14 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 15 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Idarucizumab, 2016–2026
  • Figure 16 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by AndeXXa, 2016–2026
  • Figure 17 : Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 18 : Global Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 19 : Global Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 20 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2016–2026
  • Figure 21 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2016–2026
  • Figure 22 : Global Anticoagulant Reversal Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2016–2026
  • Figure 23 : Global Anticoagulant Reversal Drugs Market Value Share, by Region, 2017 and 2026
  • Figure 24 : Global Anticoagulant Reversal Drugs Market Attractiveness, by Region, 2018–2026
  • Figure 25 : North America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 26 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 27 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 28 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 29 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 30 : North America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 31 : North America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 32 : Europe Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 33 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 34 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 35 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 36 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 37 : Europe Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 38 : Europe Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 39 : Asia Pacific Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 40 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 41 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 42 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 43 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 44 : Asia Pacific Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 45 : Asia Pacific Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 46 : Latin America Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 47 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 48 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 49 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 50 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 51 : Latin America Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 52 : Latin America Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 53 : Middle East & Africa Anticoagulant Reversal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 54 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 55 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
  • Figure 56 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 57 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Product, 2018–2026
  • Figure 58 : Middle East & Africa Anticoagulant Reversal Drugs Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 59 : Middle East & Africa Anticoagulant Reversal Drugs Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 60 : Global Anticoagulant Reversal Drugs Market Share Analysis, by Company (2018)
  • Figure 61 : Product Overview - Bausch Health Companies, Inc.
  • Figure 62 : Breakdown of Net Sales (%), by Region, 2017 - Bausch Health Companies, Inc.
  • Figure 63 : Revenue (US$ Mn), 2015–2017 - Bausch Health Companies, Inc.
  • Figure 64 : R&D Expenses (US$ Mn), 2015-2017 - Bausch Health Companies, Inc.
  • Figure 65 : Product Overview - Pfizer, Inc.
  • Figure 66 : Breakdown of Net Sales, by Region, 2017 - Pfizer, Inc.
  • Figure 67 : Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017 - Pfizer, Inc.
  • Figure 68 : R&D Intensity and Sales & Marketing Intensity - Company Level, 2016–2017 - Pfizer, Inc.
  • Figure 69 : Product Overview - Fresenius Kabi AG
  • Figure 70 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017 - Fresenius Kabi AG
  • Figure 71 : Breakdown of Net Sales, by Region, 2017 - Fresenius Kabi AG
  • Figure 72 : Breakdown of Net Sales, by Segment, 2017 - Fresenius Kabi AG
  • Figure 73 : Research & Development Cost, 2016 - 2017 (US$ Mn) - Fresenius Kabi AG
  • Figure 74 : Product Overview - Amneal Pharmaceuticals, Inc.
  • Figure 75 : Product Overview - Boehringer Ingelheim GmbH
  • Figure 76 : Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017 - Boehringer Ingelheim GmbH
  • Figure 77 : Breakdown of Net Sales, by Business and Business Segment Level, 2017 - Boehringer Ingelheim GmbH
  • Figure 78 : Breakdown of Net Sales, by Region (Company Level), 2017 - Boehringer Ingelheim GmbH
  • Figure 79 : R&D Expenditure (US$ Bn), 2013–2017 - Boehringer Ingelheim GmbH
  • Figure 80 : Product Overview: CSL Limited
  • Figure 81 : Total Revenue (US$ Mn) and Y-o-Y Growth, 2016–2018 – CSL Limited
  • Figure 82 : R&D Investment, (US$ Mn) and Y-o-Y Growth, 2016–2018 - CSL Limited
  • Figure 83 : Sales Revenue (US$ Mn) and Y-o-Y Growth, 2016–2018 - CSL Limited
  • Figure 84 : Net Profit (US$ Mn), 2016–2018 - CSL Limited
  • Figure 85 : Product Overview - Octapharma AG
  • Figure 86 : Revenue (US$ Mn) and Y-o-Y Growth, 2015–2017 - Octapharma AG
  • Figure 87 : R&D and Selling and Marketing Expenses, (US$ Mn), 2016–2017 - Octapharma AG
  • Figure 88 : Year-end Employee Headcount and Y-o-Y Growth, 2015-2017 - Octapharma AG
  • Figure 89 : Gross profit (US$ Mn) and Y-o-Y Growth, 2016–2017 - Octapharma AG
  • Figure 90 : Product Overview - Portola Pharmaceuticals, Inc.
  • Figure 91 : R&D and Selling and Marketing Expenses, (US$ Mn), 2016–2017 - Portola Pharmaceuticals, Inc.
  • Figure 92 : Revenue (US$ Mn) and Y-o-Y Growth, 2015–2017 - Portola Pharmaceuticals, Inc.
  • Figure 93 : Product Overview - Perosphere Pharmaceuticals Inc.

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report